Published in J Urol on October 01, 2005
Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers. J Endourol (2010) 2.00
Oncologic outcome after laparoscopic radical prostatectomy: 10 years of experience. Eur Urol (2008) 1.66
Comprehensive prospective comparative analysis of outcomes between open and laparoscopic radical prostatectomy conducted in 2003 to 2005. J Urol (2008) 1.43
Robot-assisted versus pure laparoscopic radical prostatectomy. World J Urol (2006) 1.16
Oncological and functional results of open, robot-assisted and laparoscopic radical prostatectomy: does surgical approach and surgical experience matter? World J Urol (2007) 1.11
Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer. World J Urol (2006) 1.02
Laparoscopic cholecystectomy only could be an appropriate treatment for selected clinical R0 gallbladder carcinoma. Surg Endosc (2007) 1.00
Prevention and management of perioperative complications in laparoscopic and endoscopic radical prostatectomy. World J Urol (2008) 0.94
Complications of endoscopic extraperitoneal radical prostatectomy (EERPE): prevention and management. World J Urol (2006) 0.89
Long-term functional and oncological results after retroperitoneal laparoscopic prostatectomy according to a prospective evaluation of 550 patients. World J Urol (2006) 0.88
Endoscopic extraperitoneal radical prostatectomy: the University of Leipzig experience of 1,300 cases. World J Urol (2007) 0.88
Laparoscopic radical prostatectomy: oncological and functional results of 126 patients with a minimum 3-year follow-up at a single Chinese institute. Asian J Androl (2009) 0.86
Evolution of endoscopic extraperitoneal radical prostatectomy (EERPE): technique and outcome. Asian J Androl (2011) 0.85
Ultrasensitive prostate specific antigen assay following laparoscopic radical prostatectomy--an outcome measure for defining the learning curve. Ann R Coll Surg Engl (2009) 0.83
Categorisation of complications of endoscopic extraperitoneal and laparoscopic transperitoneal radical prostatectomy. World J Urol (2006) 0.81
Perioperative blood loss in open retropubic radical prostatectomy - Is it safe to get operated at an educational hospital? Eur J Med Res (2009) 0.78
Long-term oncological and functional results of extraperitoneal laparoscopic radical prostatectomy: one surgical team's experience on 1,600 consecutive cases. World J Urol (2013) 0.78
New techniques and management options for localized prostate cancer. Rev Urol (2006) 0.78
Extraperitoneal robot-assisted laparoscopic radical prostatectomy: a single-center experience beyond the learning curve. World J Urol (2012) 0.77
Approach to endoscopic extraperitoneal radical prostatectomy (EERPE): the impact of previous laparoscopic experience on the learning curve. BMC Urol (2007) 0.77
Conservative management of rectal perforation after nerve sparing endoscopic extraperitoneal radical prostatectomy (nsEERPE) in a patient with a past history of polypectomy. Eur J Med Res (2009) 0.76
Laparoscopic radical prostatectomy: Oncological outcome analysis from a single-center Indian experience of 6 years. Indian J Urol (2012) 0.75
Laparoscopic radical prostatectomy. J Minim Access Surg (2005) 0.75
Complications, urinary continence, and oncologic outcomes of laparoscopic radical prostatectomy: single-surgeon experience for the first 100 cases. Prostate Cancer (2011) 0.75
Dorsal vein complex preserving technique for intrafascial nerve-sparing laparoscopic radical prostatectomy. Int J Urol (2012) 0.75
Comparison of efficacy and safety of conventional laparoscopic radical prostatectomy by the transperitoneal versus extraperitoneal procedure. Sci Rep (2015) 0.75
Laparoscopic urological oncology: here come the outcomes! J Urol (2005) 0.75
[Therapy of locoregional prostate cancer]. Wien Med Wochenschr (2007) 0.75
[Research in urologic university clinics. Assessment of current status and perspectives]. Urologe A (2006) 0.75
Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Eur Urol (2008) 2.52
Topographical anatomy of periprostatic and capsular nerves: quantification and computerised planimetry. Eur Urol (2008) 2.22
Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia (2005) 2.18
Nerve quantification and computerized planimetry to evaluate periprostatic nerve distribution-does size matter? Urology (2009) 2.14
Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume. Eur Urol (2006) 2.05
Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. Eur Urol (2006) 1.61
Intrafascial nerve-sparing endoscopic extraperitoneal radical prostatectomy. Eur Urol (2007) 1.53
Laparoscopy in German urology: changing acceptance among urologists. Eur Urol (2008) 1.51
A comparison of outcomes for interfascial and intrafascial nerve-sparing radical prostatectomy. Urology (2010) 1.50
Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia (2007) 1.49
Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men. World J Urol (2002) 1.48
Immunohistochemical distribution of cyclic GMP-dependent protein kinase-1 in human prostate tissue. Eur Urol (2007) 1.46
Laparoscopic radical prostatectomy in the UK: defining and overcoming the obstacles. BJU Int (2007) 1.39
The endoscopic extraperitoneal radical prostatectomy (EERPE): technique and initial experience. World J Urol (2002) 1.36
The learning curve for laparoscopic radical prostatectomy: an international multicenter study. J Urol (2010) 1.30
Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype. Pharmacogenet Genomics (2011) 1.27
Nerve sparing endoscopic extraperitoneal radical prostatectomy--effect of puboprostatic ligament preservation on early continence and positive margins. Eur Urol (2005) 1.15
Modular training for residents with no prior experience with open pelvic surgery in endoscopic extraperitoneal radical prostatectomy. Eur Urol (2005) 1.10
Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues. Am J Pathol (2002) 1.09
Anatomical landmarks of radical prostatecomy. Eur Urol (2006) 1.07
Ultrasound measurement of detrusor wall thickness in healthy adults. Neurourol Urodyn (2006) 1.07
RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis. Mol Cancer (2007) 1.06
Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate. Eur Urol (2006) 1.05
Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk. Arch Toxicol (2012) 1.04
MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy. Eur Radiol (2014) 1.04
Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer. World J Urol (2006) 1.03
Reduction in incidence of lymphocele following extraperitoneal radical prostatectomy and pelvic lymph node dissection by bilateral peritoneal fenestration. World J Urol (2008) 1.01
Endoscopic extraperitoneal radical prostatectomy: the University of Leipzig experience of 2000 cases. J Endourol (2008) 1.01
Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk. Arch Toxicol (2010) 1.00
Endoscopic extraperitoneal radical prostatectomy in patients with prostate cancer and previous laparoscopic inguinal mesh placement for hernia repair. World J Urol (2005) 0.98
Urinary tract injuries in patients with multiple trauma. World J Urol (2007) 0.98
Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue. Urology (2008) 0.98
Biological vascularized matrix for bladder tissue engineering: matrix preparation, reseeding technique and short-term implantation in a porcine model. J Urol (2005) 0.96
Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients. Int J Cancer (2006) 0.95
Impact of previous surgery on endoscopic extraperitoneal radical prostatectomy. Urology (2005) 0.95
Prevention and management of perioperative complications in laparoscopic and endoscopic radical prostatectomy. World J Urol (2008) 0.94
CD97, but not its closely related EGF-TM7 family member EMR2, is expressed on gastric, pancreatic, and esophageal carcinomas. Am J Clin Pathol (2002) 0.94
Intrafascial nerve-sparing endoscopic extraperitoneal radical prostatectomy. Urology (2006) 0.93
Transient receptor potential A1 (TRPA1) activity in the human urethra--evidence for a functional role for TRPA1 in the outflow region. Eur Urol (2008) 0.93
The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms. World J Urol (2008) 0.93
Alterations in connexin expression in the bladder of patients with urge symptoms. BJU Int (2005) 0.93
Endoscopic extraperitoneal radical prostatectomy after previous transurethral resection of prostate: oncologic and functional outcomes of 100 cases. Urology (2009) 0.91
Smooth muscle cells from human urinary bladder express connexin 43 in vivo and in vitro. World J Urol (2002) 0.90
Androgen and estrogen receptors in the human corpus cavernosum penis: immunohistochemical and cell culture results. World J Urol (2003) 0.90
Expression profiles of p53, p63, and p73 in benign salivary gland tumors. Virchows Arch (2002) 0.90
Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue. Cancer Epidemiol Biomarkers Prev (2007) 0.90
Urinary bladder cancer risk in relation to a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3 (IGFBP3) gene. Arch Toxicol (2011) 0.89
Endoscopic extraperitoneal radical prostatectomy: initial experience after 70 procedures. J Urol (2003) 0.89
Complications of endoscopic extraperitoneal radical prostatectomy (EERPE): prevention and management. World J Urol (2006) 0.89
Evolution of endoscopic extraperitoneal radical prostatectomy (EERPE)--technical improvements and development of a nerve-sparing, potency-preserving approach. World J Urol (2003) 0.89
Modular surgical training for endoscopic extraperitoneal radical prostatectomy. BJU Int (2005) 0.88
Endoscopic extraperitoneal radical prostatectomy: the University of Leipzig experience of 1,300 cases. World J Urol (2007) 0.88
Impact of tumor size on the long-term survival of patients with early stage renal cell cancer. World J Urol (2005) 0.88
Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. Urology (2004) 0.87
Alfuzosin: a clinically uroselective alpha1-blocker. World J Urol (2002) 0.87
Detrusor smooth muscle cells of the guinea-pig are functionally coupled via gap junctions in situ and in cell culture. Cell Tissue Res (2002) 0.86
In vitro effects of a novel class of nitric oxide (NO) donating compounds on isolated human erectile tissue. Eur Urol (2002) 0.86
Histamine receptors in human detrusor smooth muscle cells: physiological properties and immunohistochemical representation of subtypes. World J Urol (2006) 0.85
Isolation of primary endothelial and stromal cell cultures of the corpus cavernosum penis for basic research and tissue engineering. Eur Urol (2005) 0.85
The future of the oral pharmacotherapy of male erectile dysfunction: things to come. Expert Opin Emerg Drugs (2007) 0.85
Long-term follow-up after surgery for advanced colorectal carcinoma involving the urogenital tract. Eur Urol (2002) 0.85
Expression of messenger ribonucleic acid encoding for phosphodiesterase isoenzymes in human female genital tissues. J Sex Med (2007) 0.85
Interactions between cGMP- and cAMP-pathways are involved in the regulation of penile smooth muscle tone. World J Urol (2004) 0.84
Hernia repair during endoscopic (laparoscopic) radical prostatectomy. J Laparoendosc Adv Surg Tech A (2003) 0.84
Effects of various nitric oxide-donating drugs on adrenergic tension of human seminal vesicles in vitro. Urology (2003) 0.84
In vitro functional responses of isolated human vaginal tissue to selective phosphodiesterase inhibitors. World J Urol (2005) 0.84
Functional tissue engineering of autologous tunica albuginea: a possible graft for Peyronie's disease surgery. Eur Urol (2004) 0.84
Efficiency analysis of bipolar and multipolar radiofrequency ablation in an in vivo porcine kidney model using three-dimensional reconstruction of histologic section series. J Endourol (2011) 0.84
Nikolaj A. Bogoraz (1874-1952): pioneer of phalloplasty and penile implant surgery. J Sex Med (2005) 0.83
Value of frozen section biopsies during radical prostatectomy: significance of the histological results. World J Urol (2008) 0.83
SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells. Oncotarget (2014) 0.83